Skip to main content

ERRATUM article

Front. Immunol., 31 August 2022
Sec. Vaccines and Molecular Therapeutics
This article is part of the Research Topic Next Generation MSC Therapy Manufacturing, Potency and Mechanism of Action Analysis View all 15 articles

Erratum: Incorporating cryopreservation evaluations into the design of cell-based drug delivery dystems: An opinion paper

  • Frontiers Media SA, Lausanne, Switzerland

An erratum on:
Incorporating cryopreservation evaluations into the design of cell-based drug delivery systems: an opinion paper.

By Ekpo MD, Xie J, Liu X, Onuku R, Boafo GF and Tan S (2022) Front. Immunol. 13:967731.doi: 10.3389/fimmu.2022.967731

Due to a production error, there was a mistake in affiliation two of this article. Instead of “School of Pharmacy, Taipei Medical University, Taipei, Taiwan”, it should be “Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria”.

The publisher sincerely apologizes for this mistake.

The original version of this article has been updated.

Keywords: mesenchymal stem cells, cryopreservation, cryoprotectants, chemotherapy, targeted drug delivery

Citation: Frontiers Production Office (2022) Erratum: Incorporating cryopreservation evaluations into the design of cell-based drug delivery dystems: An opinion paper. Front. Immunol. 13:1020829. doi: 10.3389/fimmu.2022.1020829

Received: 16 August 2022; Accepted: 16 August 2022;
Published: 31 August 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.